# Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer

> **NCT01797471** · NA · TERMINATED · sponsor: **University of Miami** · enrollment: 1 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer
- NSCLC

## Interventions

- **RADIATION:** Lattice Extreme Ablative Dose (LEAD) Radiation Therapy

## Key facts

- **NCT ID:** NCT01797471
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-03
- **Primary completion:** 2013-05-31
- **Final completion:** 2013-11-06
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2017-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01797471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01797471, "Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01797471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*